Similar to GSK-J4, KDM6A/ KDM6B-knockdown minimally effected basal tumor growth but dramatically potentiated the effects of cisplatin, again with evidence of tumor regression, and all mice remained tumor-free for over 90 days after a single dose of cisplatin (Fig. 3). Here, KDM6A is linked to neoplasm.